menu

Quintiles Library

Show Filters
Press Release
RESEARCH TRIANGLE PARK, N.C. – November 14, 2005 – Quintiles Transnational Corp. today announced financial results for the quarter ended September 30, 2005. Net revenue for third quarter 2005 was $470.3 million, an increase of 19% from net revenue of $396.5 million for third quarter 2004. Profit contribution from Quintiles' Product Development and Commercial Services...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – November 10, 2005 – Quintiles Transnational Corp. today announced that it will conduct a live webcast of its third quarter 2005 earnings release conference call on Tuesday, Nov. 15, at 11:00 a.m. EST.To access the live webcast, go to www.quintiles.com/Corporate_Info/Broadcast_Center (Access expired). Interested parties can access the...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – Sept. 30, 2005 – Quintiles Transnational Corp. today announced the completion of the previously announced agreement with Aptuit, Inc., to enter a strategic partnership. Aptuit has acquired three Quintiles business units – Preclinical Services, Pharmaceutical Sciences and Clinical Trial Supplies – for approximately $125 million. The...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – August 19, 2005 – Quintiles Transnational Corp. today announced that its newly formed subsidiary, Duloxetine Royalty Sub (“Royalty Sub”), intends to issue $150 million of Duloxetine Secured Notes, plus as much as $50 million to $150 million of additional notes, depending on market and other conditions. Quintiles expects to use the net...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – August 12, 2005 – Quintiles Transnational Corp. today announced financial results for the quarter ended June 30, 2005. Net revenue for second quarter 2005 was $537.4 million, an increase of 26% from net revenue of $425.8 million for second quarter 2004. Contribution from Quintiles' Product Development and Commercial Services groups totaled...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – August 9, 2005 – Quintiles Transnational Corp. today announced that it will conduct a live webcast of its second quarter 2005 earnings release conference call on Friday, Aug. 12, at 1:00 p.m. EDT.To access the live webcast, go to www.quintiles.com/Corporate_Info/Broadcast_Center (Access expired). Interested parties can access the webcast or...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – August 2, 2005 – Quintiles Transnational Corp. today announced the appointment of an expert in the regulation of pharmaceutical and biotechnology products, Edward Tabor, M.D., as Executive Director, Regulatory & Technical Services. Dr. Tabor joins Quintiles from the FDA, where he created the antiviral regulatory review program in the 1980s...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – July 21, 2005 – Quintiles Transnational Corp. today announced the appointment of Kiyotaka Fujii as President and Chief Executive Officer of Quintiles Transnational Japan K.K. (Quintiles Japan) as of August 1, 2005. An executive with more than 20 years of international business experience, Fujii will lead all operations of Quintiles Japan....
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – July 19, 2005 – Quintiles Transnational Corp., the world's leading pharmaceutical services organization, announced today that it has signed an agreement with Aptuit Inc., an emerging company focused on streamlining and supporting the early drug development process, to enter a strategic partnership. Aptuit will acquire three Quintiles...
Read More
Press Release
Hong Kong, Singapore, Research Triangle Park, NC, USA – June 9, 2005 – Three global companies have announced a joint venture to commercialize pharmaceutical products in the Asia Pacific region. Partners in the joint venture, which will have an investment fund totaling US$112 million, include leading Asia Pacific pharmaceutical services group, Interpharma Asia Pacific,...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – June 2, 2005 – Quintiles Transnational Corp. today announced that Quintiles Laboratories Asia (QLAB Asia) has amended its existing agreement with Peking Union Medical College Hospital (PUMCH) to enhance central laboratory services in China. The new amended agreement with PUMCH enhances services for customers by allowing Quintiles central...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – May 31, 2005 – Quintiles Inc., the North American clinical development subsidiary of Quintiles Transnational Corp., and Miami Children's Hospital in Florida today announced an alliance for clinical research. The alliance allows Quintiles and Miami Children's Hospital to collaborate on clinical research that will give investigators access to...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – May 13, 2005 – Quintiles Transnational Corp. today announced financial results for the quarter ended March 31, 2005. Net revenue for first quarter 2005 was $492.4 million, an increase of 16% from net revenue of $423.2 million for the same quarter in 2004. Contribution for Quintiles' Product Development and Commercial Services groups...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – May 12, 2005 – Quintiles Transnational Corp. today announced it has entered a partnership with Roche for clinical study management services. The two companies have signed a three-year preferred provider agreement, which will give Roche more flexibility and efficiency in the development of its product pipeline. Analysts regard the Roche...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – May 11, 2005 – Quintiles Transnational Corp. today announced that it will conduct a live webcast of its first quarter 2005 earnings release conference call on Monday, May 16, at 11:00 a.m. EDT.To access the webcast on May 16, go to www.quintiles.com/Corporate_Info/Broadcast_Center (Access expired). Interested parties can access the webcast...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – March 7, 2005 – Quintiles Transnational Corp. today announced financial results for the year and quarter ended Dec. 31, 2004. Net revenue for 2004 was $1.78 billion versus $1.63 billion in 2003. Contribution for Quintiles' Product Development and Commercial Services groups totaled $808.1 million for 2004 versus $713.7 million for 2003. ...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – March 3, 2005 – Quintiles Transnational Corp. today announced that it will conduct a live webcast of its fourth quarter 2004 earnings release conference call on Wednesday, March 9, at 11:00 a.m. EST.To access the webcast on March 9, go to www.quintiles.com/Corporate_Info/Broadcast_Center (Access expired). Interested parties can access the...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – February 22, 2005 – Quintiles Transnational Corp. today announced that its Medical and Scientific Services organization has hired six more physicians for their medical expertise. The physicians are Rose Blackburne, M.D., and Harish Dave, M.D., who are in Quintiles' Rockville, Md., office; Marc Capobianco, M.D., and Lori Stone, M.D., in the...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – February 18, 2005 – Quintiles Inc., the North American clinical development subsidiary of Quintiles Transnational Corp., and the University of North Carolina at Chapel Hill today announced the creation of a new alliance for clinical research.The alliance will give more patients and investigators access to clinical research, help develop new...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – November 22, 2004 – Quintiles Transnational Corp. today announced the appointment of Stephen DeCherney, M.D., MPH, as President, Clinical Development Services Americas. Dr. DeCherney will lead Quintiles' clinical development strategy and operations in North and Latin America. He joins Quintiles from PRA International, where he served most...
Read More